AMGEN, the largest biotechnology firm worldwide, develops, produces, and distributes biopharmaceutical products that are manufactured using recombinant DNA technology. AMGEN places top priority on developing new therapies for diseases that so far have not or only insufficiently been treatable.
Due to their cellular origin and complex manufacturing process, AMGEN’s biopharmaceutical products are as unique as the human body itself. We will continue to be measured by the improvements that we bring to the quality of life of patients. For, even nowadays, only five per cent of cancer patients are receiving treatment that is up to date with the latest medical research, and that must change.
AMGEN – your health is our vision.
Address
Year of foundation
1980
Schweiz: 1989
Business activity
Biotechnology, pharmaceutics
